Ausgabe 11/2020
Inhalt (25 Artikel)
A comprehensive overview on the molecular biology of human glioma: what the clinician needs to know
P. D. Delgado-López, P. Saiz-López, R. Gargini, E. Sola-Vendrell, S. Tejada
Cellular immunotherapy: a clinical state-of-the-art of a new paradigm for cancer treatment
Á. Rodríguez Pérez, D. Campillo-Davo, V. F. I. Van Tendeloo, D. Benítez-Ribas
The role of macrophages during breast cancer development and response to chemotherapy
S. Tao, Z. Zhao, X. Zhang, X. Guan, J. Wei, B. Yuan, S. He, D. Zhao, J. Zhang, Q. Liu, Y. Ding
Apolipoproteins, as the carrier proteins for lipids, are involved in the development of breast cancer
Y. Zhou, G. Luo
Multidisciplinary consensus statement on the clinical management of patients with pancreatic cancer
E. Martin-Perez, J. E. Domínguez-Muñoz, F. Botella-Romero, L. Cerezo, F. Matute Teresa, T. Serrano, R. Vera
Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology
P. García-Alfonso, R. García-Carbonero, J. García-Foncillas, P. Pérez-Segura, R. Salazar, R. Vera, S. Ramón y Cajal, J. Hernández-Losa, S. Landolfi, E. Musulén, M. Cuatrecasas, S. Navarro
The effectiveness and safety of thromboprophylaxis in cancer patients based on Khorana score: a meta-analysis and systematic review of randomized controlled trials
Y. Bao, B. Gao, P. Yan, L. Tian, K. Yang
Invasive and in situ cervical cancer associated with pregnancy: analysis from the French cancer network (CALG: Cancer Associé à La Grossesse)
A. Puchar, A. S. Boudy, L. Selleret, A. Arfi, C. Owen, S. Bendifallah, E. Darai
Immune status and the efficacy of adjuvant radiotherapy for patients with localized Merkel cell carcinoma of the head and neck
M. Yusuf, J. Gaskins, M. E. May, S. Mandish, W. Wall, W. Fisher, P. Tennant, J. Jorgensen, J. Bumpous, N. Dunlap
Evaluating anti-tumor activity of palbociclib plus radiation in anaplastic and radiation-induced meningiomas: pre-clinical investigations
A. Das, M. Alshareef, J. L. Martinez Santos, G. B. F. Porto, D. G. McDonald, L. K. Infinger, W. A. Vandergrift III, S. M. Lindhorst, A. K. Varma, S. J. Patel, D. Cachia
Incidence of venous thromboembolism in patients with colorectal cancer according to oncogenic status
L. Ortega Morán, P. García Alfonso, I. Aguilar Caballero, B. Morón García, V. Tirado Anula, M. de Toro Carmena, J. Soto Alsar, N. Gutiérrez Alonso, M. Bringas Beranek, M. Martín Jiménez, A. J. Muñoz Martín
Hepatic resection and blood transfusion increase morbidity after cytoreductive surgery and HIPEC for colorectal carcinomatosis
C. Soldevila-Verdeguer, J. J. Segura-Sampedro, C. Pineño-Flores, P. Sanchís-Cortés, X. González-Argente, R. Morales-Soriano
Radiation-induced lymphopenia: the main aspects to consider in immunotherapy trials for endometrial and cervical cancer patients
K. Holub, A. Vargas, A. Biete
ECO-SEOM-SEEO safety recommendations guideline for cancer patients receiving intravenous therapy
I. Magallón-Pedrera, J. Pérez-Altozano, J. A. Virizuela Echaburu, C. Beato-Zambrano, P. Borrega-García, J. C. de la Torre-Montero
Urinary microRNAs expression in prostate cancer diagnosis: a systematic review
R. M. Paiva, D. A. G. Zauli, B. S. Neto, I. S. Brum
Targeting Toll-like receptor 4 with CLI-095 (TAK-242) enhances the antimetastatic effect of the estrogen receptor antagonist fulvestrant on non-small cell lung cancer
S. Fan, Y. Liao, W. Qiu, L. Li, D. Li, X. Cao, B. Ai
The impact of surgical margin status on prostate cancer-specific mortality after radical prostatectomy: a systematic review and meta-analysis
B. Zhang, J. Zhou, S. Wu, M. Guo, Y. Zhang, R. Liu
Safety in radiation oncology: transposition of directive 2013/59/EURATOM in the Spanish Radiation Oncology Departments—recommendations for its adequate and effective application
J. Pardo Masferrer, C. Prieto Martín, C. Ferrer Albiach
Reduce proliferation of human bone marrow cells from acute myeloblastic leukemia with minimally differentiation by blocking lncRNA PVT1
A. Ghadiri, M. Sharifi, V. Mehrzad, P. Bagheri
The low expression of miR-1976 in plasma samples indicating its biological functions in the progression of breast cancer
J. Wang, G. Ma, X. Han, M. Liang, X. Wang, T. Xia, S. Wang
Neutrophil function is impaired in paediatric patients with malignancy and may be a useful clinical marker
J. Reiné, K. Cooper, A. Sewell, J. Lyall, C. Thorbinson, E. Hincks, D. M. Ferreira, B. Pizer, B. Morton
Combination of statin/vitamin D and metastatic castration-resistant prostate cancer (CRPC): a post hoc analysis of two randomized clinical trials
A. Carretero-González, D. Lora, R. Manneh, D. Lorente, D. Castellano, G. de Velasco
Neutrophil-to-lymphocyte ratio and lactate dehydrogenase as biomarkers for urothelial cancer treated with immunotherapy
G. L. Banna, R. Di Quattro, L. Malatino, G. Fornarini, A. Addeo, M. Maruzzo, V. Urzia, F. Rundo, H. Lipari, U. De Giorgi, U. Basso
Comment on: “ECO-SEOM-SEEO safety recommendations guideline for cancer patients receiving intravenous therapy”, looking to the future
G. Ortiz-Miluy, E. Natarén-Cigarroa, M. A. Cubero-Pérez
Radiotherapy after prostatectomy in high‑risk prostate cancer
G. Roviello, D. Villari, G. Nesi, B. Detti